Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain training without drugs: new hope for ADHD teens?

NCT ID NCT07285681

Symptom relief Sponsor: Tanta University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether neurofeedback—a non-invasive brain training technique—can reduce symptoms of attention deficit hyperactivity disorder (ADHD) in teenagers. Researchers in Tanta, Egypt, are enrolling 40 participants aged 12 to 18. The approach uses real-time brain activity feedback to help teens learn to self-regulate their focus and behavior, aiming to improve attention and reduce hyperactivity without medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Neurofeedback (a brain-training device that uses EEG to teach self-regulation of brain activity)
What this could lead to
If it works, this could offer a non-drug option for managing ADHD symptoms in teenagers, potentially reducing reliance on medication.
What could go wrong
This is a small, early-stage study with only 40 participants and no control group, so results may not be widely applicable. The benefits may also fade after treatment ends.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants are between 12- 18 years old * Both sexes are included (males \& females). * Willingness to participate to complete study procedures Exclusion Criteria: * Unwilling to participate in the study. * Other Psychiatric disorders. * Intellectual disability

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit disorder with hyperactivity (ADHD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention deficit disorder with hyperactivity (ADHD)

Contacts and locations

Locations

  • NeuroPsychiatry Department - Faculty of Medicine - Tanta University

    Tanta, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.